Document Detail


Ongoing role of pulmonary embolectomy.
MedLine Citation:
PMID:  3228760     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Pulmonary embolism remains a frequent and often fatal disorder. For the majority of patients, anticoagulation with heparin followed by warfarin represents the primary mode of treatment. Thrombolytic therapy is recommended for the patient with massive pulmonary embolism that has produced hypotension. Embolectomy is reserved for the patient with post embolic systemic hypotension who has an absolute contraindication to thrombolysis or who deteriorates despite thrombolytic therapy. Following successful embolectomy the surgeon must treat the complications of the surgery and prevent recurrence. Complications include cerebral infarction, pulmonary infarction and endobronchial hemorrhage, right ventricular failure, local or systemic bleeding and venous stasis. A case of successful pulmonary embolectomy with a complicated postoperative course is presented and the pathophysiology and treatment of the complications are discussed.
Authors:
R G Masters; A Koshal; L A Higginson; W J Keon
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  4     ISSN:  0828-282X     ISO Abbreviation:  Can J Cardiol     Publication Date:  1988 Oct 
Date Detail:
Created Date:  1989-04-19     Completed Date:  1989-04-19     Revised Date:  2008-04-09    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  CANADA    
Other Details:
Languages:  eng     Pagination:  347-51     Citation Subset:  IM    
Affiliation:
University of Ottawa Heart Institute, Ottawa Civic Hospital, Ontario.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adrenal Gland Diseases / etiology
Chest Pain / etiology
Dyspnea / etiology
Female
Heparin / adverse effects,  therapeutic use
Humans
Hypotension / etiology
Middle Aged
Pain / etiology
Postoperative Complications*
Pulmonary Embolism / surgery*
Syncope / etiology
Warfarin / therapeutic use
Chemical
Reg. No./Substance:
81-81-2/Warfarin; 9005-49-6/Heparin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Colour flow imaging in severe mitral and aortic regurgitation.
Next Document:  Complete heart block in an Inuit family.